C 2012

Regulatory Cells and Multiple Myeloma

MUTHU RAJA, Karthick Raja and Roman HÁJEK

Basic information

Original name

Regulatory Cells and Multiple Myeloma

Authors

MUTHU RAJA, Karthick Raja (356 India, guarantor, belonging to the institution) and Roman HÁJEK (203 Czech Republic, belonging to the institution)

Edition

Rijeka, Multiple Myeloma - An Overview, p. 33-60, 28 pp. Oncology, 2012

Publisher

InTech

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30200 3.2 Clinical medicine

Country of publisher

Croatia

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

References:

RIV identification code

RIV/00216224:14110/12:00057252

Organization unit

Faculty of Medicine

ISBN

978-953-307-768-0

Keywords in English

Multiple Myeloma; Tumor Cells; Immune System; Regulatory Cells
Změněno: 12/4/2013 17:49, Ing. Mgr. Věra Pospíšilíková

Abstract

V originále

Large evidence is available in hematological malignancies and solid tumors for elevated level of various regulatory and suppressor cells which impede anti-tumor responses. Therefore, targeting the regulatory cells could be a useful strategy to enhance the anti-tumor immunity. Approaches of depletion or inhibition of regulatory cells showed countable benefits in pre-clinical and clinical studies of some cancers including renal cell carcinoma, metastatic melanoma and colorectal carcinoma. Targeting regulatory T cells in a non-specific approach might cause detrimental autoimmune toxicities which is the key issue. Further studies are necessary to identify tumor associated regulatory cells which will enhance the depletion of specific regulatory cells but not the global population of regulatory cells.

Links

GAP304/10/1395, research and development project
Name: Analýza klonálních progenitorů plazmatických buněk u monoklonálních gamapatií
Investor: Czech Science Foundation
LC06027, research and development project
Name: Univerzitní výzkumné centrum - Česká myelomová skupina (Acronym: LC MGUS)
Investor: Ministry of Education, Youth and Sports of the CR, University Research Centre - Czech Myeloma Group
MSM0021622434, plan (intention)
Name: Od klasických prognostických markerů ke klinicky aplikovatelným farmakogenomickým a farmakoproteomickým projektům u mnohočetného myelomu a monoklonálních gamapatií
Investor: Ministry of Education, Youth and Sports of the CR, From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies
NS10406, research and development project
Name: Vytvoření prognostického panelu u pacientů s monoklonální gamapatií nejasného významu s cílem zabránění transformace v maligní onemocnění.
Investor: Ministry of Health of the CR